Life Sciences Times

PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics Announce Collaboration

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise

iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening

Xlife Sciences AG: Antiviral drug candidate for SARS-CoV-2

Cancer Researchers Can Assess Microsatellite Instability (MSI) Through New Lens with Expanded Promega System

Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis

Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach